CASE REPORT
Progressive spastic paraparesis in a young male
 
More details
Hide details
1
Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Poland
 
 
Submission date: 2017-04-27
 
 
Acceptance date: 2017-09-26
 
 
Online publication date: 2018-03-05
 
 
Publication date: 2019-11-17
 
 
Corresponding author
Beata Zwiernik   

Department of Neurology and Neurosurgery, School of Medicine, Collegium Medicum, University of Warmia and Mazury in Olsztyn, Warszawska 30, 10-082 Olsztyn, Poland. Tel.: +4889 524 53 84.
 
 
Pol. Ann. Med. 2018;25(1):134-138
 
KEYWORDS
CONFLICT OF INTEREST
None declared.
 
REFERENCES (26)
1.
Moser HW. Adrenoleukodystrophy: phenotype, genetics, pathogenesis and therapy. Brain. 1997;120(Pt 8):1485–1508. https://doi.org/10.1093/brain/....
 
2.
Aubourg P. [Adrénoleucodystrophie liée à l’X]. Annales d’Endocrinologie. 2007;68: 317–324 [in French]. https://doi.org/10.1016/j.ando....
 
3.
Bezman L, Moser HW. Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet. 1998;76(5):415–419. https://doi.org/10.1002/(SICI)...<415::AID-AJMG9>3.0.CO;2-L.
 
4.
Mosser J, Lutz Y, Stoeckel ME, et al. The gene responsible for adrenoleukodystrophy encodes a peroxisomal membrane protein. Hum Mol Genet.1994;3(2):265–271. https://doi.org/10.1093/hmg/3.....
 
5.
Kemp S, Pujol A, Waterham H, et al. ABCD1 mutations and the X-linked adrenoleukodystrophy mutation database: role in diagnosis and clinical correlations. Hum Mutat. 2001;18(6):499–515. https://doi.org/10.1002/humu.1....
 
6.
Kemp S, Wanders R. Biochemical aspects of X-linked adrenoleukodystrophy. Brain Pathol. 2010;20(4):831–837. https://doi.org/10.1111/j.1750....
 
7.
Hein S, Schönfeld P, Kahlert S, Reiser G. Toxic effects of X-linked adrenoleukodystrophy-associated, very long chain fatty acids on glial cells and neurons from rat hippocampus in culture. Hum Mol Genet. 2008;17(12):1750–1761. https://doi.org/10.1093/hmg/dd....
 
8.
Whitcomb RW, Linehan WM, Knazek RA. Effects of long-chain, saturated fatty acids on membrane microviscosity and adrenocorticotropin responsiveness of human adrenocortical cells in vitro. J Clin Invest. 1988;81(1):185–188. https://doi.org/10.1172/JCI113....
 
9.
Berger J, Forss-Petter S, Eichler F. Pathophysiology of X-linked adrenoleukodystrophy. Biochimie. 2014;98:135–142. https://doi.org/10.1016/j.bioc....
 
10.
Moser HW, Mahmood A, Raymond GV. X-linked adrenoleukodystrophy. Nat Clin Pract Neurol. 2007;3(3):140–151. https://doi.org/10.1038/ncpneu....
 
11.
Mosser J, Douar AM, Sarde CO, et al. Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters. Nature. 1993;361(6414):726-730. https://doi.org/10.1038/361726....
 
12.
Neuromuscular Disease Center. Washington University, St. Louis, MO USA [online database] Familial Spinal Cord Syndromes X-linked/Adrenomyeloneuropathy. Available at: http://neuromuscular.wustl.edu....
 
13.
Engelen M, Kemp S, de Visser M, et al. X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis. 2012;7:51. https://doi.org/10.1186/1750-1....
 
14.
Brennemann W, Köhler W, Zierz S, Klingmüller D. Testicular dysfunction in adrenomyeloneuropathy. Eur J Endocrinol. 1997;137(1):34–43. https://doi.org/10.1530/eje.0.....
 
15.
Moser HW, Moser AB, Naidu S, Bergin A. Clinical aspects of adrenoleukodystrophy and adrenomyeloneuropathy. Dev Neurosci. 1991;13(4–5):254–261. https://doi.org/10.1159/000112....
 
16.
Höftberger R, Kunze M, Weinhofer I, et al. Distribution and cellular localization of adrenoleukodystrophy protein in human tissues: implications for X-linked adrenoleukodystrophy. Neurobiol Dis. 2007;28(2):165–174. https://doi.org/10.1016/j.nbd.....
 
17.
Edwin D, Speedie L, Naidu S, Moser H. Cognitive impairment in adult-onset adrenoleukodystrophy. Mol Chem Neuropathol. 1990;12(3):167–176. https://doi.org/10.1007/BF0315....
 
18.
Kemp S, Bergerc J, Aubourgd P. X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological. Biochim Biophys Acta. 2012;1822(9):1465–1474. https://doi.org/10.1016/j.bbad....
 
19.
van Geel BM, Assies J, Weverling GJ, Barth PG. Predominance of the adrenomyeloneuropathy phenotype of X-linked adrenoleukodystrophy in The Netherlands: a survey of 30 kindreds. Neurology. 1994;44(12):2343–2346. https://doi.org/10.1212/WNL.44....
 
20.
Engelen M, Kemp S. Facts on ALD April 15th, 2016. ALD database. http://www.x-ald.nl/clinical-d....
 
21.
Cappa M, Bizzarri C, Giannone G, Aiello C, Di Biase A. Is subclinical adrenal failure in adrenoleukodystrophy/adrenomyeloneuropathy reversible? J Endocrinol Invest. 2011;34(10):753–756.
 
22.
Abel A, Danek A, Borasio GD, Witt TN. [X chromosomal bulbospinal neuropathy (X-BSN, Kennedy syndrome): an illness with repetitive triplet sequences. Case report, differential diagnosis and molecular genetics aspects]. Nervenarzt. 1996;67(12):1011–1019 [in German]. https://doi.org/10.1007/s00115....
 
23.
Tuck RR, O’Neill BP, Gharib H, Mulder DW. Familial spastic paraplegia with Kallmann’s syndrome. J Neurol Neurosurg Psychiatry. 1983;46(7):671–674. https://doi.org/10.1136/jnnp.4....
 
24.
Moser HW, Raymond GV, Lu SE, et al. Follow-up of 89 asymptomatic patients with adrenoleukodystrophy treated with Lorenzo’s oil. Arch Neurol. 2005;62(7):1073–1080. https://doi.org/10.1001/archne....
 
25.
Engelen M, Ofman R, Dijkgraaf MG, et al. Lovastatin in X-linked adrenoleukodystrophy. N Eng J Med. 2010;362(3):276–277. https://doi.org/10.1056/NEJMc0....
 
26.
Mahmood A, Raymond G, Dubey P, Peters C, Moser HW. Survival analysis of haematopoietic cell transplantation for childhood cerebral X-linked adrenoleukodystrophy: a comparison study. Lancet Neurol. 2007;6(8):687–692. https://doi.org/10.1016/S1474-....
 
Journals System - logo
Scroll to top